Cytoreduction

PROCEDURE4 trials

Sponsors

Cantonal Hospital of St. Gallen, Azienda Ospedaliera San Giovanni Battista, Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia, Richard van Hillegersberg

Conditions

B-cell Lymphoma RefractoryEpithelial Ovarian CancerFallopian Tube CarcinomaGastric CancerHIPECPeritoneal CarcinomatosisPeritoneal Carcinomatosis From Ovarian CancerPrimary Peritoneal Carcinoma

Phase 2

Thiotepa, Busulfan and Fludarabin for pt With Refractory/Early Relapsed Aggressive B-cell Non Hodgkin Lymphomas

Azienda Ospedaliera San Giovanni BattistaB-cell Lymphoma Refractory

Start: 2013-02-28End: 2015-02-28Target: 42Updated: 2014-07-08

Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study

TerminatedNCT03150628

Richard van HillegersbergGastric Cancer, HIPEC, Peritoneal Carcinomatosis

Start: 2017-08-01End: 2018-04-23Updated: 2019-04-17

Phase 3

Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma

Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaFallopian Tube Carcinoma, Peritoneal Carcinomatosis From Ovarian Cancer, Primary Peritoneal Carcinoma

Start: 2012-02-29End: 2018-12-31Target: 32Updated: 2017-12-13

Unknown Phase

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

TerminatedNCT00968799

Cantonal Hospital of St. GallenEpithelial Ovarian Cancer, Fallopian Tube Carcinoma

Start: 2008-02-29End: 2012-12-31Updated: 2023-08-08

Related Papers

Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies.

2019-05-0810 citations